[go: up one dir, main page]

AR028316A1 - Gen de masa nsea elevada del cromosoma 11q13.3 - Google Patents

Gen de masa nsea elevada del cromosoma 11q13.3

Info

Publication number
AR028316A1
AR028316A1 ARP010101640A ARP010101640A AR028316A1 AR 028316 A1 AR028316 A1 AR 028316A1 AR P010101640 A ARP010101640 A AR P010101640A AR P010101640 A ARP010101640 A AR P010101640A AR 028316 A1 AR028316 A1 AR 028316A1
Authority
AR
Argentina
Prior art keywords
nsea
chromosome
elevated mass
mass gene
gene
Prior art date
Application number
ARP010101640A
Other languages
English (en)
Original Assignee
Genome Therapeutics Corp
Creighton University School Of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/543,771 external-priority patent/US6780609B1/en
Priority claimed from US09/544,398 external-priority patent/US6770461B1/en
Application filed by Genome Therapeutics Corp, Creighton University School Of filed Critical Genome Therapeutics Corp
Publication of AR028316A1 publication Critical patent/AR028316A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Addiction (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Pregnancy & Childbirth (AREA)
ARP010101640A 2000-04-05 2001-04-05 Gen de masa nsea elevada del cromosoma 11q13.3 AR028316A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/543,771 US6780609B1 (en) 1998-10-23 2000-04-05 High bone mass gene of 1.1q13.3
US09/544,398 US6770461B1 (en) 1998-10-23 2000-04-05 High bone mass gene of 11q13.3
PCT/US2000/016951 WO2001077327A1 (en) 2000-04-05 2000-06-21 THE HIGH BONE MASS GENE OF 11q13.3

Publications (1)

Publication Number Publication Date
AR028316A1 true AR028316A1 (es) 2003-05-07

Family

ID=27067425

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010101640A AR028316A1 (es) 2000-04-05 2001-04-05 Gen de masa nsea elevada del cromosoma 11q13.3

Country Status (11)

Country Link
EP (1) EP1268775B1 (es)
JP (1) JP2004515209A (es)
CN (1) CN1454256A (es)
AR (1) AR028316A1 (es)
AU (2) AU5626900A (es)
BR (1) BR0017197A (es)
CA (1) CA2402410A1 (es)
IL (1) IL151904A0 (es)
MX (1) MXPA02009791A (es)
NZ (1) NZ521769A (es)
WO (1) WO2001077327A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555654B1 (en) 1997-04-15 2003-04-29 The Wellcome Trust Limited As Trustee For The Wellcome Trust LDL-receptor
US7244577B2 (en) 1997-04-15 2007-07-17 Merck & Co., Inc. Method of screening for modulator of LRP5 activity
AU733722B2 (en) 1997-04-15 2001-05-24 Merck Sharp & Dohme Corp. Novel LDL-receptor
JP2004507236A (ja) * 2000-08-18 2004-03-11 プロスケリア 骨粗鬆症の診断および治療に有用な調節遺伝子および系
EP1483288A4 (en) * 2001-05-11 2005-09-21 Genome Therapeutics Corp HBM VARIANTS MODULATING BONE MASS AND LIPID LEVELS
US7514594B2 (en) 2001-05-11 2009-04-07 Wyeth Transgenic animal model of bone mass modulation
AU2002342734B2 (en) * 2001-05-17 2007-07-26 Oscient Pharmaceuticals Corporation Reagents and methods for modulating Dkk-mediated interactions
AU2003292404A1 (en) * 2002-12-13 2004-07-09 Oxagen Limited Genetic susceptibility
WO2006004066A1 (ja) * 2004-07-02 2006-01-12 Locomogene, Inc. S1-5を含有するタンパク質製剤
JPWO2006004066A1 (ja) * 2004-07-02 2008-04-24 株式会社ロコモジェン Ｓ１−５を含有するタンパク質製剤
JP6745220B2 (ja) * 2013-09-16 2020-08-26 ツェーエムエム−フォルシュングスツェントルム フュア モレクラレ メディツィン ゲーエムベーハー 骨髄性悪性腫瘍の診断のための突然変異体カルレチクリン

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7392696A (en) * 1995-10-04 1997-04-28 Warner-Lambert Company Compounds, compositions and methods for inhibiting the binding of proteins containing an sh2 domain to cognate phosphorylated proteins
US5691153A (en) * 1996-09-06 1997-11-25 Creighton University Genetic markers to detect high bone mass
AU733722B2 (en) * 1997-04-15 2001-05-24 Merck Sharp & Dohme Corp. Novel LDL-receptor
BE1011331A6 (fr) * 1997-08-20 1999-07-06 Univ Catholique De Louvain Hal Polypeptide associe au peroxysome, sequence nucleotidique encodant ledit polypeptide et leur utilisation dans le diagnostic et/ou le traitement de maladies ou de lesions pulmonaires.
CA2319493A1 (en) * 1998-03-18 1999-09-23 Regine Bohacek Heterocyclic signal transduction inhibitors, compositions containing them
JP2002539843A (ja) * 1999-03-26 2002-11-26 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ５０個のヒト分泌タンパク質
CN100469792C (zh) * 2000-05-26 2009-03-18 奥赛恩特药品公司 通过Zmax1或HBM基因调节脂质水平
JP2004507236A (ja) * 2000-08-18 2004-03-11 プロスケリア 骨粗鬆症の診断および治療に有用な調節遺伝子および系

Also Published As

Publication number Publication date
MXPA02009791A (es) 2004-09-06
NZ521769A (en) 2004-12-24
EP1268775A1 (en) 2003-01-02
EP1268775B1 (en) 2008-11-19
JP2004515209A (ja) 2004-05-27
AU2000256269A1 (en) 2002-01-10
CN1454256A (zh) 2003-11-05
WO2001077327A1 (en) 2001-10-18
IL151904A0 (en) 2003-04-10
CA2402410A1 (en) 2001-10-18
BR0017197A (pt) 2003-01-14
AU5626900A (en) 2001-10-23
AU2000256269B2 (en) 2006-11-02

Similar Documents

Publication Publication Date Title
AP2004003002A0 (en) azabicyclic-substituted fused-heteroaryl compoundsfor the treatment of disease.
DE60236093D1 (de) Entfernbarer stent
BR0212250B1 (pt) produto de cuidado pessoal.
FI20010694A0 (fi) Implantti
BR0208970B1 (pt) produto absorvente com ajuste melhorado.
BR0208971B1 (pt) produto absorvente com ajuste melhorado.
BR0208969B1 (pt) produto absorvente com ajuste melhorado.
AR028316A1 (es) Gen de masa nsea elevada del cromosoma 11q13.3
DE50209070D1 (de) Sämaschine
IT1310418B1 (it) Bracciale biorigenerante.
ES1052634Y (es) Peladora de almendra, semilla de albaricoque y productos similares.
NO20041295L (no) Tieno(1,3)oksazin-4-oner med lipaseinhiberende aktivitet
ITRM20000644A0 (it) Procedimento per la fabbricazione di stampi.
ITRM20020038A1 (it) Posate sospese c 323.
ITCO20030008A1 (it) Gioco del 19.
ITRM990211V0 (it) Il gioco del postino.
ES1048305Y (es) Hebilla autoblocante.
FI20011798A7 (fi) Pintakytkin
ITRE20010032V0 (it) Gioiello.
SK3057U (sk) Viacradový vertikálny zásobník
ITSV20010001U4 (it) Vedi invenzione n. 16 del 1998
ES1053452Y (es) Cortadora-formadora de piezas de masa panificable.
UA5744S (uk) Лоток хлібний
ES1046569Y (es) Conjunto helice de alabes de inclinacion regulable.
IT247486Y1 (it) Manufatto alveolato di oreficeria , gioielleria o bigiotteria , deltipo della croce .

Legal Events

Date Code Title Description
FB Suspension of granting procedure